Service Corporation International Raises Its Dividend - But the Cash That Funds It Is Coming From a Different Business Than It Was Five Years Ago

Service Corporation International announced another quarterly dividend increase in May 2026, lifting the payout to $0.36 per share, a 6% jump from the previous $0.34. It is the 11th straight year of increases and the 20th consecutive year of payments. For someone tracking the cash that actually hits your brokerage account, the headline is reassuring. But the more interesting question is not whether the dividend was raised. It is whether the machine producing the cash that funds it is still the same one that was running five years ago.

The answer is no. SCI is undergoing a quiet structural shift, and if you only watch the dividend line on a screen, you will miss it.

What is actually producing the cash

SCI operates 1,495 funeral homes and 505 cemeteries across 44 states and eight Canadian provinces under brands including Dignity Memorial. For decades, the core revenue engine was straightforward: families without a pre-arranged plan walked in, and the funeral service was delivered at a healthy margin. At-need funeral volume was the heartbeat of the business.

That heartbeat is slowing. In Q2 2026, comparable at-need funeral services fell 3% to 44,482 from 45,873 a year earlier. At the same time, the core cremation rate rose to 58.0% from 57.4%. Cremation generates less revenue per case than traditional burial. The combination of fewer full-service funerals and more cremations means the funeral segment's comparable gross margin dropped 130 basis points to 18.5% from 19.8%.

The company raised prices to compensate. Average revenue per comparable funeral service grew 3.3% to $6,016. But pricing power has a ceiling. Families absorb a certain amount of inflation before the math stops working for them. The result was funeral gross profit falling 5.8% despite revenue per case climbing.

What is replacing it

The offset is preneed. Preneed contracts are agreements families sign today - paying in advance for funeral or cemetery services delivered years from now. The cash sits in regulated trust funds while the revenue obligation sits on the balance sheet as deferred income, recognized later when the service is performed.

In Q2 2026, comparable funeral preneed sales grew 7% to $323.3 million. Cemetery preneed sales production grew 8% to $399.5 million. SCI's deferred revenue backlog stood at $1.82 billion, with $6.12 billion held in preneed trust funds and another $2.52 billion in cemetery perpetual care trusts. These trust funds earned 7.7% annualized returns in the quarter - 8.0% on funeral trusts, 7.8% on cemetery trusts - and those investment gains flowed directly into cemetery revenue.

This is the structural shift. The at-need funeral transaction is being replaced by two revenue sources: the eventual recognition of preneed contracts sold today, and the investment income earned on the trust funds that hold families' prepayments while they wait. The cemetery segment, which carries the bulk of this trust machinery, grew revenue 5% and held margins near 33%, showing no sign of the compression afflicting the funeral side.

The dividend against the cash engine

The quarterly dividend of $0.36 per share translates to roughly $1.44 annually. At the current share count of approximately 138 million shares, that is about $200 million per year in dividend payments. SCI's full-year 2026 adjusted free cash flow guidance sits at roughly $750 million - up from $637 million in 2025. The dividend consumes roughly 27% of projected free cash flow.

The trailing payout ratio is 34.6%, well below the 50-60% range where dividend safety starts to require close watching. Operating cash flow in Q2 alone reached $238.8 million on an adjusted basis, more than four times the $49 million in dividends paid that quarter. The cash is not strained.

But the dividend's safety profile is not the interesting part. The interesting part is what the payout ratio tells you about capital allocation priorities. With free cash flow growing 18% and the dividend consuming a shrinking slice of it, SCI is using the extra cash for something else: share buybacks. The company returned $363 million to shareholders in the first half of 2026 through dividends and repurchases, with buybacks accounting for the bulk. In Q2 alone, $123 million went to buybacks against $49 million in dividends.

This is not a company trying to preserve yield at all costs. This is a company that views the dividend as a floor and buybacks as the growth mechanism. For an income investor, the distinction matters: the dividend will not be cut, but it also will not grow aggressively enough to be the primary return driver. The total return architecture here is dividends plus share count reduction, not dividend acceleration.

The leverage question

The balance sheet demands attention. Long-term debt stands at roughly $5.1 billion against $1.54 billion in shareholders' equity, for a debt-to-equity ratio of 345%. Net debt to EBITDA sits at approximately 3.77x, which management says is comfortably within its 3.5- to 4.0x target range. Interest expense was $64.7 million in Q2.

This leverage level is not unusual for a capitalized operator with heavy real estate, but it does set a boundary. If funeral margins keep compressing and the preneed engine does not compensate on a cash basis fast enough, debt service becomes a heavier percentage of the cash flow pie. The company's liquidity position - roughly $1.6 billion including $260 million in cash and $1.4 billion under its credit facility - provides cushion. But the leverage is real, and in a higher-rate environment, refinancing cycles can be unforgiving for speculative-grade issuers.

The counterargument here is simple: operating cash flow of $238.8 million in a single quarter, against $64.7 million in interest, produces a coverage ratio that makes near-term debt risk manageable. The trust fund returns also add a layer of yield that most debtors do not have. SCI is not in distress. It is leveraged, but the cash flow is large enough to service that leverage for now.

What the stock is telling you

At $85.14, SCI trades at roughly 21.6 times trailing earnings and 12.6 times EV/EBITDA. The stock is up about 9% year-to-date and roughly 11% over the past 20 days, but essentially flat over the broader six-month window. The dividend yield of 1.63% does not position this as an income play in the traditional sense. You would need to buy a substantial position for the quarterly checks to move the needle in a retirement portfolio.

What SCI offers instead is dividend durability in a business model that has very low cyclical sensitivity. Deaths do not go out of fashion. The preneed backlog is a queue of contracted future revenue that does not depend on economic conditions. And the 20-year dividend track record is long enough to have survived more than one recession.

The risk is not that the dividend gets cut. The risk is that you pay a multiple-digit P/E for a stock whose yield barely exceeds a Treasury note and whose primary secular headwind - cremation replacing burial, fewer at-need services, margin compression - runs counter to its largest legacy revenue source. The preneed engine may be sufficient to offset that headwind. The Q2 results suggest it is. But the business you are buying in 2026 is structurally different from the one that generated dividend growth through 2015.

The income investor's take

If you already hold SCI and collect the dividend, there is no reason to sell based on the dividend declaration itself. The payout is well-covered, the streak is deep, and the cash flow supports it. The lower price periods that SCI occasionally visits - the stock ranges between roughly $68 and $91 over the past year - are opportunities to buy more dividend-paying shares, assuming the preneed model continues to hold.

If you are evaluating SCI as a new income position, set your expectations accordingly. A 1.6% yield will not fund much on its own. The value proposition here is stability, not income intensity. For a portfolio that needs yield, SCI fills a small stabilizer role - the kind of holding you own alongside higher-yielding assets to reduce the chance that one broken dividend derails your cash flow plan. It is not a hero. It is ballast.

The condition that would change this view is a sustained deterioration in funeral gross margins that the preneed engine cannot offset on a cash basis. If comparable funeral margins fall below 16% for multiple consecutive quarters while preneed sales stall, the cash flow that currently looks generous could narrow quickly, and the leverage would start to bite. Until that happens, the income stream is intact. The question is simply whether the 21x multiple is worth paying for ballast.